Setmelanotide · 2024 11 13
Setmelanotide for the treatment of severe early-childhood genetic obesity.
Journal Article
Open attributed record →PubMed-attributed venue
The lancet. Diabetes & endocrinology
5 selected PubMed bibliographic records attributed to The lancet. Diabetes & endocrinology. Venue attribution is reproduced from PubMed and does not imply endorsement, editorial affiliation, article quality, or scientific validity.
Bibliographic records
5 selected records.
Peptide profiles
2 connected profiles.
Publication years
3 attributed years.
Attributed bibliography
Selected records
Setmelanotide · 2024 04 30
Setmelanotide for the treatment of acquired hypothalamic obesity: a phase 2, open-label, multicentre trial.
Journal Article, Clinical Trial, Phase II, Multicenter Study, Research Support, Non-U.S. Gov't
Open attributed record →Setmelanotide · 2024 04 30
Setmelanotide: new promise for the treatment of hypothalamic obesity?
Journal Article, Comment
Open attributed record →Dulaglutide · 2021 06 18
Dulaglutide for erectile dysfunction in type 2 diabetes.
Journal Article, Comment
Open attributed record →Setmelanotide · 2020 10 30
Setmelanotide: what does it mean for clinical care of patients with obesity?
Journal Article, Comment
Open attributed record →